IBX 13.0% 4.0¢ imagion biosystems limited

The Dr Burzynski problem, page-9

  1. 338 Posts.
    lightbulb Created with Sketch. 42
    Nobody is going to stop IBX based on its technology reducing biopsies. Big pharma doesn’t do biopsies.
    I assume you are acquainted with how much imaging goes on presently seeking to elucidate what is a benign and what is a suspicious lesion and its likelihood of spread. Anything that assists this process will be seized with both hands.
    Only IBX is stopping IBX.
    The rest is convenient conspiracy theory.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.